Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Girard

Showing results (151-160 of 396) with videos related to

Pageof 40
Sort By:
JBMR Plus|July 22, 2025
Epidemiology of bone metastasis in France between 2009 and 2018Clarisse Marchal, Manon Belhassen, Gaëlle Désaméricq, et al.
Sante Mentale Au Quebec|May 26, 2022
[Early Detection and Intervention for Psychosis: Why and How?]Bastian Bertulies-Esposito, Roxanne Sicotte, Srividya N Iyer, et al.
Cancer Immunology, Immunotherapy : CII|November 25, 2021
Discontinuation of immune checkpoint inhibitor (ICI) above 18 months of treatment in real-life patients with advanced non-small cell lung cancer (NSCLC): INTEPI, a multicentric retrospective studyGeoffroy Bilger, Nicolas Girard, Hélène Doubre, et al.
Journal of Bone Oncology|January 21, 2020
Bone decalcification to assess programmed cell death ligand 1 expression in bone metastases of non-small cell lung cancersGuillaume Pontarollo, Cyrille B Confavreux, Jean-Baptiste Pialat, et al.
Healthcare Quarterly (Toronto, Ont.)|April 20, 2026
Advancing Integrated Care for Youth: The Role of Family Physicians in an Urban, Multidisciplinary ServiceAnne-Sophie Thommeret-Carrière, Julie Cotton, Nicolas Girard, et al.
Cancer Medicine|June 7, 2026
Retrospective Analysis of HER2 Testing, Treatment Patterns, and Clinical Outcomes in Patients With Locally Advanced or Metastatic NSCLC With HER2 Mutations in FranceDidier Debieuvre, Pauline Macouillard, Xavier Quantin, et al.
Lung Cancer (Amsterdam, Netherlands)|March 25, 2018
Programmed cell death-ligand 1 (PD-L1) expression is associated with RAS/TP53 mutations in lung adenocarcinomaPierre Serra, Arthur Petat, Jean-Michel Maury, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 7, 2014
Efficacy of first-line chemotherapy in patients with advanced lung sarcomatoid carcinomaThibault Vieira, Nicolas Girard, Mony Ung, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 17, 2014
Assessing the multimodal management of advanced solitary fibrous tumors of the pleura in a routine practice settingOlivier Bylicki, Damien Rouvière, Philippe Cassier, et al.
Lung Cancer (Amsterdam, Netherlands)|December 12, 2018
Systemic treatments for thymoma and thymic carcinoma: A systematic reviewThierry Berghmans, Valérie Durieux, Stéphane Holbrechts, et al.
Pageof 40

Showing results (151-160 of 396) with videos related to

Sort By:
Pageof 40
JBMR Plus|July 22, 2025
Epidemiology of bone metastasis in France between 2009 and 2018Clarisse Marchal, Manon Belhassen, Gaëlle Désaméricq, et al.
Sante Mentale Au Quebec|May 26, 2022
[Early Detection and Intervention for Psychosis: Why and How?]Bastian Bertulies-Esposito, Roxanne Sicotte, Srividya N Iyer, et al.
Cancer Immunology, Immunotherapy : CII|November 25, 2021
Discontinuation of immune checkpoint inhibitor (ICI) above 18 months of treatment in real-life patients with advanced non-small cell lung cancer (NSCLC): INTEPI, a multicentric retrospective studyGeoffroy Bilger, Nicolas Girard, Hélène Doubre, et al.
Journal of Bone Oncology|January 21, 2020
Bone decalcification to assess programmed cell death ligand 1 expression in bone metastases of non-small cell lung cancersGuillaume Pontarollo, Cyrille B Confavreux, Jean-Baptiste Pialat, et al.
Healthcare Quarterly (Toronto, Ont.)|April 20, 2026
Advancing Integrated Care for Youth: The Role of Family Physicians in an Urban, Multidisciplinary ServiceAnne-Sophie Thommeret-Carrière, Julie Cotton, Nicolas Girard, et al.
Cancer Medicine|June 7, 2026
Retrospective Analysis of HER2 Testing, Treatment Patterns, and Clinical Outcomes in Patients With Locally Advanced or Metastatic NSCLC With HER2 Mutations in FranceDidier Debieuvre, Pauline Macouillard, Xavier Quantin, et al.
Lung Cancer (Amsterdam, Netherlands)|March 25, 2018
Programmed cell death-ligand 1 (PD-L1) expression is associated with RAS/TP53 mutations in lung adenocarcinomaPierre Serra, Arthur Petat, Jean-Michel Maury, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 7, 2014
Efficacy of first-line chemotherapy in patients with advanced lung sarcomatoid carcinomaThibault Vieira, Nicolas Girard, Mony Ung, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 17, 2014
Assessing the multimodal management of advanced solitary fibrous tumors of the pleura in a routine practice settingOlivier Bylicki, Damien Rouvière, Philippe Cassier, et al.
Lung Cancer (Amsterdam, Netherlands)|December 12, 2018
Systemic treatments for thymoma and thymic carcinoma: A systematic reviewThierry Berghmans, Valérie Durieux, Stéphane Holbrechts, et al.
Pageof 40